Series B funding round for Millendo Therapeutics raising $62M in January 2016
Series B funding round for Millendo Therapeutics raising $62M in January 2016
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| University Fund | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$108M
Top Valuation
-
Millendo Therapeutics raised $62M in a Series B round.
The round was announced on 01/01/16.
The round was led by New Enterprise Associates.